Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2021-12-20 00:00:00 ET · period of report 2021-12-16 · accession 0001883850-21-000032 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2021-12-20 | 2021-12-16 | REGN | VAGELOS P ROY | Dir | I - Discretionary | $634.98 | -126 | 2,202 | -5% | -$80.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-16 | I | D | 107 | $635.03 | 2,095 | I By 401(k) Plan | — | — | (F1) Represents volume-weighted average price of sales of 107 shares of Company stock on December 16, 2021 at prices ranging from $635.00 to $635.06. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 16, 2021 at each separate price. |
| 2 | Common | Common Stock | 2021-12-16 | I | D | 19 | $634.70 | 2,202 | I By 401(k) Plan | — | — |